Thursday, December 07, 2006

Micro-Cap Spotlight: Clinical Data Inc.



Stockhouse Canada - We haven't even yet touched the subject of "Vilazodone," Clinical Data's experimental depression treatment, which is approaching Phase III pivotal trials, with almost 200 of 400 patients already chosen. Vilazodone tablets are already being
Source: www.stockhouse.ca

Real solutions for your real estate needs.
USA Today - Late in the day, the panel's chairwoman, Kyra Becker of the University of Washington School of Medicine, told Cyberonics that "it's unclear" whether the depression treatment should be approved. At 4:10 p.m., the panel took a break. A few minutes later
Source: www.usatoday.com

Duloxetine Has Less Effect on Male Sexual Function Than Escitalopram
Medscape News - NEW YORK (Reuters Health) May 24 - Among men with major depression, treatment with duloxetine (Cymbalta) is associated with less worsening of sexual function than is escitalopram (Lexapro), investigators reported this week at the American Psychiatric
Source: www.medscape.com

Depression treatment may take as many as four tries
Detroit News - The final stage of a landmark federal study on treating depression suggests that two-thirds of sufferers eventually can be helped if they are patient enough to keep trying medications until they find one that works. Thirteen percent of the 123 study
Source: www.detnews.com


Click here for more information about depression quiz depression quiz